Here are six observations:
1. The market totaled $6.61 billion in 2014, and is expected to hit $8.63 billion by 2020.
2. In 2014, the reconstructive devices segment captured 45 percent of the market share.
3. In terms of applications, the knee segment dominated the market accounting for 19 percent of the market.
4. Arthroscopy devices dominated the market in 2014, in terms of the treatments sector.
5. The Americas dominated the space, accounting for 43 percent of the global market. Europe came in second, followed by the Asia-Pacific region.
6. Dominant market players include:
• Arthrex in Naples, Fla.
• Arthrocare in Austin, Texas
• Zimmer Biomet in Warsaw, Ind.
• Stryker Corp. in Kalamazoo, Mich.
• Wright Medical Technology in Memphis, Tenn.
• DJO Global in Vista, Calif.
• OttoBock Healthcare in Duderstadt, Germany
• Ossur in Reykjavik, Iceland
More articles on sports medicine:
ACL tear rates rise among kids — 6 takeaways
Children’s Healthcare of Atlanta to partner with MLB’s Atlanta Braves and The Ryan Seacrest Foundation: 3 notes
Tria Orthopaedic Center to sponsor NHL’s Minnesota Wild’s new practice facility — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
